Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05194566 · ClinicalTrials.gov registry record · NA
Neurostimulation for the Treatment of Post-Stroke Aphasia
A NA study of Post-stroke Aphasia, sponsored by Qviti S.A..
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT05194566 is a NA study of Post-stroke Aphasia that is actively recruiting participants, run by Qviti S.A.. The registered enrollment target is 64 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05194566, a NA study of Post-stroke Aphasia, is actively recruiting participants, sponsored by Qviti S.A..
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.
Conditions Studied
Interventions
- DEVICE tACS
Study Locations (2)
Illinois
- Think & Speak Lab at Shirley Ryan AbilityLab - Chicago
New York
- Abilities Research Center at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05194566
The ClinicalTrials.gov registry entry for NCT05194566 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qviti S.A., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post-stroke Aphasia appearing as the primary indexed condition, and to 1 intervention - of which tACS is the first listed.
NCT05194566 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT05194566 about?
NCT05194566 is a clinical study titled "Neurostimulation for the Treatment of Post-Stroke Aphasia". The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.
What is the current status of trial NCT05194566?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2023-09-06. Estimated completion is 2026-12.
What conditions does trial NCT05194566 study?
This clinical trial studies the following conditions: Post-stroke Aphasia.
What interventions are being tested in trial NCT05194566?
The interventions under investigation include: tACS (DEVICE).
Who is sponsoring clinical trial NCT05194566?
This trial is sponsored by Qviti S.A., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05194566 being conducted?
This trial has 2 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.